Summit Roundtables

Tuesday, March 24

9:30-10:00 am Roundtable Discussions
Roundtable Discussions are informal, moderated discussions, allowing participants to exchange ideas and experiences and develop future collaborations around a focused topic. Each discussion will be led by a facilitator who keeps the discussion on track and the group engaged. To get the most out of this format, please come prepared to share examples from your work, be a part of a collective, problem-solving session, and participate in active idea sharing.
More roundtables will be added soon. Please check back for updates.

The New Wave: How AI is Driving Women’s Health Innovation
Imen Maaroufi Clark, Founder & CEO, Prickly Pear Health

Rebuilding Credibility: The Currency of Trust in Women’s Health Innovation
Denise Bronner, PhD, Founder & CEO, Empactful Ventures

Market Access Strategies in Women's Health
Brittany Barreto, PhD, CEO, FemHealth Insights

Actionable Strategies for Overcoming Translational Hurdles in Women’s Health Innovation
Sophia Ononye, PhD, MPH, MBA, Founder & CEO, The Sophia Consulting Firm

Closing Gaps in Women's Health with Policy & Advocacy
Liz Powell, Esq., MPH, Founder of Women's Health Advocates and G2G Consulting

How to Effectively Leverage Technology to Accelerate Drug Development for Women's Health
Petrina Kamya, PhD, Global Head of AI Platforms & Vice President, Insilico Medicine; President, Insilico Medicine Canada
Ewa Lis, PhD, Founder & CEO, Koliber Biosciences
Nikki Simpson, Principal Investigator, In Vivo Pharmacology, PostEra

• Leveraging AI for the discovery of novel targets and drug repurposing
• Using machine learning to identify potent, drug-like small-molecules
• Utilizing novel drug delivery technologies designed specifically for women
• Using tools to understand disparity in female drug pharmacokinetics and dosing

Key Learnings Going from Bench to the Clinic
Marlena Fejzo, PhD, Assistant Professor, Center for Genetic Epidemiology, Keck School of Medicine, University of Southern California; 2024 Time Women of the Year
Linda Malkas, PhD, Professor of Molecular Diagnostics and Experimental Therapeutics; Dean for Translational Science and External Affairs, City of Hope National Medical Center
Aritro Sen, PhD, Co-Founder & CSO, Maipl Therapeutics Inc.

• Finding biological relevance and overcoming translational challenges
• Gaps in developing commercially viable targets and leads
• Lack of FDA guidance and clinical endpoints
• Success stories, lessons learned, or events that catalyzed change

Bridging Preclinical and Clinical Data in Women’s Health
Michael Liebman, PhD, Managing Director, IPQ Analytics, LLC
Nisha Perez, ScD, MS, MSPM, Head of DMPK & Clinical Pharmacology, HotSpot Therapeutics
Sophie Zaaijer, PhD, Principal Investigator, University of California Riverside

• Sex-stratified PK dosing and monitoring and drug–hormone interaction studies 
• The impact of perimenopause and menopause on therapeutic development
• Piloting sex-responsive, FDA-aligned trial designs and clinical protocols

Future of Women's Healthcare Roundtables
Vasanta Pundarika, CEO & Founder, Lotuspring
In these dynamic discussion-led sessions, have more informal discussions around the current opportunities and challenges for the key conditions in women’s health. Share and exchange ideas around crucial areas and leave with new knowledge and connections.

Topics include:

1. Fertility in Focus
2. Maternal Meet-up
3. Menopause Mindshare

Programs